We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
American Vanguard Corp
AVD
$74.1M
| $211K | ﹤0.01% |
18,230
-462
| -2% | -$5.67K |
|
2677
DHI Group
DHX
$178M
| $211K | ﹤0.01% |
28,853
+432
| +2% | +$3.48K |
|
|
KE
2678
Kimball Electronics
KE
$593M
| $211K | ﹤0.01% |
17,689
-354
| -2% | -$4.37K |
|
|
RNET
2679
DELISTED
RigNet, Inc.
RNET
| $211K | ﹤0.01% |
8,278
+79
| +1% | +$2.15K |
|
2680
Immersion
IMMR
$254M
| $210K | ﹤0.01% |
18,682
-333
| -2% | -$4.04K |
|
2681
Virtu Financial
VIRT
$5.11B
| $210K | ﹤0.01% |
9,181
-3,632
| -28% | -$83.3K |
|
2682
Vanguard S&P 500 ETF
VOO
$971B
| $210K | ﹤0.01% |
+1,193
| New | +$222K |
|
|
GPX
2683
DELISTED
GP Strategies Corp.
GPX
| $210K | ﹤0.01% |
9,219
+90
| +1% | +$2.45K |
|
2684
Myers Industries
MYE
$1.26B
| $209K | ﹤0.01% |
15,604
-479
| -3% | -$7.21K |
|
|
PKD
2685
DELISTED
Parker Drilling Company
PKD
| $209K | ﹤0.01% |
5,299
-216
| -4% | -$9.12K |
|
2686
Camden National
CAC
$979M
| $208K | ﹤0.01% |
7,713
+367
| +5% | +$9.78K |
|
2687
Plug Power
PLUG
$2.73B
| $207K | ﹤0.01% |
113,162
+576
| +0.5% | +$1.23K |
|
2688
Tredegar Corp
TG
$263M
| $207K | ﹤0.01% |
15,860
-542
| -3% | -$9.05K |
|
2689
Clean Energy Fuels
CLNE
$421M
| $206K | ﹤0.01% |
45,882
-865
| -2% | -$4.49K |
|
2690
Forrester Research
FORR
$200M
| $206K | ﹤0.01% |
6,542
-8,762
| -57% | -$289K |
|
|
KBAL
2691
DELISTED
Kimball International
KBAL
| $206K | ﹤0.01% |
21,779
-133
| -0.6% | -$1.5K |
|
|
OLP
2692
One Liberty Properties
OLP
$547M
| $205K | ﹤0.01% |
9,609
-305
| -3% | -$6.72K |
|
2693
West Bancorporation
WTBA
$477M
| $205K | ﹤0.01% |
10,940
-660
| -6% | -$12.7K |
|
|
SALE
2694
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $205K | ﹤0.01% |
24,882
-680
| -3% | -$7.92K |
|
2695
Ezcorp Inc
EZPW
$1.85B
| $204K | ﹤0.01% |
33,012
-1,178
| -3% | -$7.46K |
|
2696
Tejon Ranch
TRC
$467M
| $204K | ﹤0.01% |
9,631
-80
| -0.8% | -$1.88K |
|
|
DNR
2697
DELISTED
Denbury Resources, Inc.
DNR
| $204K | ﹤0.01% |
83,557
+31,622
| +61% | +$122K |
|
2698
NeoGenomics
NEO
$1.74B
| $203K | ﹤0.01% |
35,436
+2,047
| +6% | +$12.7K |
|
|
PPBI
2699
DELISTED
Pacific Premier Bancorp
PPBI
| $203K | ﹤0.01% |
9,967
-1,163
| -10% | -$22.1K |
|
2700
Vince Holding Corp
VNCE
$77.6M
| $203K | ﹤0.01% |
5,913
-11,706
| -66% | -$965K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.